4 enrolling by invitation. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Enrolling by invitation 4 |
Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV Tirzepatide - Human Immunodeficiency Virus (HIV), Metabolic Dysfunction Associated Steatotic Liver Disease | Phase 4 | Enrolling by invitation | National Taiwan University Clinical Trial Center | 60 | 2026-06-25 | 2026-07-20 |
| Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women semaglutide or tirzepatide, Lifestyle modification intervention - Obesity, Menopause | Phase 4 | Enrolling by invitation | Mayo Clinic | 30 | 2025-05-01 | 2026-07-20 |
| Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) early time restricted Mediterranean diet, Mysimba - Diabetes Mellitus, Type 2, Liver Fibrosis | Phase 4 | Enrolling by invitation | Carmen Dietvorst | 70 | 2025-04-14 | 2026-04-21 |
| Antibiotic Prophylaxis in High-Risk Arthroplasty Patients Cephalexin, Doxycycline, Cefadroxil - Infections Joint Prosthetic, Overweight or Obesity | Phase 4 | Enrolling by invitation | Mayo Clinic | 4618 | 2020-06-11 | 2026-07-06 |
Obesity (4) · Diabetes Mellitus (3) · Dyslipidemias (2) · Acquired Immunodeficiency Syndrome (1) · Autoimmune Diseases (1) · Diabetes Mellitus, Type 2 (1) · Fatty Liver (1) · Hypertension (1) · Intermittent Fasting (1) · Liver Cirrhosis (1) · Liver Diseases (1) · Metabolic Syndrome (1) · Renal Insufficiency, Chronic (1) · Tobacco Use (1)
Body Weight (4) · Nutrition Disorders (4) · Nutritional and Metabolic Diseases (4) · Overnutrition (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Endocrine System Diseases (3) · Glucose Metabolism Disorders (3) · Metabolic Diseases (3) · Behavior (2) · Immune System Diseases (2) · Lipid Metabolism Disorders (2) · Pathologic Processes (2) · Urogenital Diseases (2) · Blood-Borne Infections (1)
Tirzepatide (2) · Bupropion (1) · Cefadroxil (1) · Cephalexin (1) · Diet Therapy (1) · Diet, Mediterranean (1) · Doxycycline (1) · Naltrexone (1) · bupropion hydrochloride, naltrexone hydrochoride drug combination (1) · semaglutide (1)
Mayo Clinic (2) · Carmen Dietvorst (1) · National Taiwan University Clinical Trial Center (1)
United States (2) · Netherlands (1) · Taiwan (1)
Manuel Castro Cabezas, Dr. (1) · Maria D. Hurtado Andrade, M.D., Ph.D. (1) · Nicholas Bedard, MD (1)